Wanbury P/B Ratio
Wanbury (WANBURY) P/B ratio is 10.92 (High), book value per share ₹17.88 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Wanbury share price screener.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
WANBURY P/B Ratio — Valuation Insights & Book Value Analysis
Wanbury price-to-book ratio interpretation, valuation status and historical context — current P/B 10.92 (High). Read WANBURY dividend track record for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 10.92, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 53.5% below historical average
- Trading at premium to sector average PB of -0.01
Wanbury P/B Ratio Historical Trend
WANBURY annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore WANBURY value investing to estimate fundamental worth using multiple valuation models.
WANBURY Historical P/B Ratio — Book Value Per Share & Year-End Price
Wanbury annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 12.67 | ₹17.88 | ₹226.60 | ₹59 | High |
| 2024 | 34.32 | ₹8.48 | ₹291.18 | ₹28 | High |
WANBURY vs Healthcare Peers — P/B Ratio Comparison
Wanbury P/B 10.92 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |